Old Web
English
Sign In
Acemap
>
authorDetail
>
Dave Sprengers
Dave Sprengers
Erasmus University Medical Center
Cancer research
Cytotoxic T cell
T cell
Medicine
Immune checkpoint
3
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer.
2021
Frontiers in Immunology
Zhouhong Ge
Maikel P. Peppelenbosch
Dave Sprengers
Jaap Kwekkeboom
Show All
Source
Cite
Save
Citations (3)
588 Targeting GITR enhances human tumour-infiltrating T cell functionality in mismatch repair proficient primary colorectal carcinoma and liver metastases
2020
Journal for ImmunoTherapy of Cancer
Yannick Rakké
Lucia Campos Carrascosa
Adriaan van Beek
Valeska de Ruiter
Michael Doukas
Susan Ter Borg
Pascal G. Doornebosch
Maarten Vermaas
Erwin van der Harst
Peter-Paul L.O Coene
Dirk J. Grünhagen
Cornelis Verhoef
Jan N. M. IJzermans
Dave Sprengers
Jaap Kwekkeboom
Show All
Source
Cite
Save
Citations (1)
SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma
2015
Oncogene
Pratika Y. Hernanda
Kan Chen
Das Am
K. Sideras
Wenshi Wang
Juan Li
Wanlu Cao
S J Bots
Kodach Ll
de Man Ra
Jan N. M. IJzermans
Harry L.A. Janssen
Andrew P. Stubbs
Dave Sprengers
Marco J. Bruno
Herold J. Metselaar
ten Hagen Tl
Jaap Kwekkeboom
Maikel P. Peppelenbosch
Qiuwei Pan
Show All
Source
Cite
Save
Citations (44)
1